Signia Newest, World’s-First Hearing Aid Innovations, Motion Charge&Go X and Active Pro X, Now Available to Veterans

Signia today announced its cutting-edge Motion Charge&Go X and Active Pro hearing aids are now available to U.S. Department of Veterans Affairs (VA) audiologists treating military veterans, as well as audiologists within the U.S. Department of Defense (DoD), for active military, and Indian Health Service (IHS), for American Indians.

The new solutions join the stylish Signia Styletto X hearing aids and the Signia Pure Charge&Go X as trusted by the VA to improve veterans’ hearing.

Technology to Enhance Human Performance 

According to the Hearing Loss Association of Americahearing issues are the most common service-connected disability among veterans and more than 2.7 million veterans currently receive treatment or disability compensation for hearing problems. In selecting Signia’s most advanced hearing aids for fitting by VA audiologists, the government agency entrusted with the health and wellbeing of veterans has ensured access to worlds-first technologies that enhance human performance.

“Signia is committed to improving the quality of life for all veterans through better hearing,” said John Murray, Signia’s Vice President of Government Services. We understand the needs of the VA audiology community and the patients they serve, and we’re proud to deliver our most innovative Signia Xperience technology via our Motion Charge&Go X and Active Pro hearing aids. Now, Audiologists and their patients can select from a wider array of Signia devices to fit veterans’ hearing needs and lifestyles.”

The Signia Motion Charge&Go X is Signia’s newest family of behind-the-ear (BTE) hearing solutions for addressing all levels of hearing loss in a sleek form factor and with industry-leading rechargeability. Three models—the Motion Charge&Go X, P X, and SP X—are available through the VA. The Motion Charge&Go SP X is the world’s first rechargeable super power hearing aid and is capable of running up to 61 hours per charge.

Signia Active Proan innovative hearing aid to fight stigma, is another option for VA, DoD, and IHS audiologists. It represents a new category of hearing aid, with a discreet design to fight the stigma that might otherwise cause veterans to avoiding wearing hearing aids. This in-the-ear, non-custom hearing aid won’t interfere with face masks and requires fewer visits for fittings, as no ear impression is needed. The Active Pro features ClickSleeves 2.0 technology for a quick fit while ensuring the hearing aids remain firmly and comfortably in place. Its battery lasts all day on a single charge and works with an included portable charger that can extend battery life by three days. 

“Signia’s broad portfolio of hearing solutions ensures audiologists can always identify a model to meet their patients’ specific needs,” Murray continued. “Many features of Signia hearing aids are ideally suited to veterans, such as support for Signia TeleCare and Signia Assistant, for veterans who can’t easily get to a VA facility.”

Signia Xperience for Better Hearing 

Both the Signia Motion X family and Signia Active Pro are powered by the Signia Xperience platform, a collection of worlds-first audiology and technology features that allow audiologists and their patients to tailor hearing experiences to varying conditions and preferences.

Both the Signia Motion Charge&Go X family and Signia Active Pro include Bluetooth connectivity and run the Signia app, which offers access to Signia TeleCare and Signia Assistant. Signia TeleCare is a telehealth solution that allows audiologists to consult with their patients remotely. Signia Assistant uses artificial intelligence to make automatic adjustments.

The Signia app also gives patients access to Signia’s revolutionary Face Mask Mode, which improves audibility for wearers communicating with someone wearing a face mask, as well as the company’s unique tinnitus notch therapy, which is customized to the unique frequency of each wearer’s tinnitus.

“Signia’s mission is to enhance human performance through an innovative combination of audiology and technology,” Murray concluded. “When treating veterans, in partnership with the Audiologist, we believe it’s not just a matter of correcting for hearing loss; it’s about providing them with a solution that enables them to perform at their very best – personally, professionally, and continuously.

In addition to these newest products, Signia has recently expanded its Government Services team, welcoming more dedicated professionals to deliver an enhanced level of service to audiologists. More details here.

SourceSignia

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”